Baker DL - Search Results

1

Molecular basis for lysophosphatidic acid receptor antagonist selectivity.

Sardar VM, Bautista DL, Fischer DJ, Yokoyama K, Nusser N, Virag T, Wang DA, Baker DL, Tigyi G, Parrill AL. Sardar VM, et al. Among authors: baker dl. Biochim Biophys Acta. 2002 May 23;1582(1-3):309-17. doi: 10.1016/s1388-1981(02)00185-3. Biochim Biophys Acta. 2002. PMID: 12069842 Review.

2

Pharmacological characterization of phospholipid growth-factor receptors.

Tigyi G, Fischer DJ, Baker D, Wang DA, Yue J, Nusser N, Virag T, Zsiros V, Liliom K, Miller D, Parrill A. Tigyi G, et al. Ann N Y Acad Sci. 2000 Apr;905:34-53. doi: 10.1111/j.1749-6632.2000.tb06536.x. Ann N Y Acad Sci. 2000. PMID: 10818440 Review.

3

Quantitative analysis of lysophosphatidic acid in human blood fractions.

Baker DL, Umstot ES, Desiderio DM, Tigyi GJ. Baker DL, et al. Ann N Y Acad Sci. 2000 Apr;905:267-9. doi: 10.1111/j.1749-6632.2000.tb06557.x. Ann N Y Acad Sci. 2000. PMID: 10818461 No abstract available.

4

Structural features of EDG1 receptor-ligand complexes revealed by computational modeling and mutagenesis.

Parrill AL, Baker DL, Wang DA, Fischer DJ, Bautista DL, Van Brocklyn J, Spiegel S, Tigyi G. Parrill AL, et al. Among authors: baker dl. Ann N Y Acad Sci. 2000 Apr;905:330-9. doi: 10.1111/j.1749-6632.2000.tb06573.x. Ann N Y Acad Sci. 2000. PMID: 10818477 Review. No abstract available.

5

Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate.

Parrill AL, Wang D, Bautista DL, Van Brocklyn JR, Lorincz Z, Fischer DJ, Baker DL, Liliom K, Spiegel S, Tigyi G. Parrill AL, et al. Among authors: baker dl. J Biol Chem. 2000 Dec 15;275(50):39379-84. doi: 10.1074/jbc.M007680200. J Biol Chem. 2000. PMID: 10982820 Free article.

6

Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors.

Liliom K, Sun G, Bünemann M, Virág T, Nusser N, Baker DL, Wang DA, Fabian MJ, Brandts B, Bender K, Eickel A, Malik KU, Miller DD, Desiderio DM, Tigyi G, Pott L. Liliom K, et al. Among authors: baker dl. Biochem J. 2001 Apr 1;355(Pt 1):189-97. doi: 10.1042/0264-6021:3550189. Biochem J. 2001. PMID: 11256963 Free PMC article.

7

Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry.

Baker DL, Desiderio DM, Miller DD, Tolley B, Tigyi GJ. Baker DL, et al. Anal Biochem. 2001 May 15;292(2):287-95. doi: 10.1006/abio.2001.5063. Anal Biochem. 2001. PMID: 11355863

8

Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors.

Fischer DJ, Nusser N, Virag T, Yokoyama K, Wang Da, Baker DL, Bautista D, Parrill AL, Tigyi G. Fischer DJ, et al. Among authors: baker dl. Mol Pharmacol. 2001 Oct;60(4):776-84. Mol Pharmacol. 2001. PMID: 11562440

9

Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood.

Sano T, Baker D, Virag T, Wada A, Yatomi Y, Kobayashi T, Igarashi Y, Tigyi G. Sano T, et al. J Biol Chem. 2002 Jun 14;277(24):21197-206. doi: 10.1074/jbc.M201289200. Epub 2002 Apr 2. J Biol Chem. 2002. PMID: 11929870 Free article.

10

Plasma lysophosphatidic acid concentration and ovarian cancer.

Baker DL, Morrison P, Miller B, Riely CA, Tolley B, Westermann AM, Bonfrer JM, Bais E, Moolenaar WH, Tigyi G. Baker DL, et al. JAMA. 2002 Jun 19;287(23):3081-2. doi: 10.1001/jama.287.23.3081. JAMA. 2002. PMID: 12069669 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters